Pharmacokinetics of 5-fluorouracil and cyclophosphamide in depression rats

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 4, 2012, Pages 427-436

  Duan, J J ^a   Zhou, T ^a   Chen, X ^b   Wang, Y ^a   Wen, Y G ^c   Xu, F ^a  

^a Fengxian Central Hospital   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Guangzhou Brain Hospital   (China)

Author keywords

5 fluorouracil; Chronic unpredicted mild stress; Cyclophosphamide; Pharmacokinetics; Serotonin

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; ALKYLATING AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CYTOCHROME P450; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD SAMPLING; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MENTAL STRESS; NONHUMAN; RAT; REVIEW; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; AFFECT; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BLOOD; ENZYMOLOGY; LIVER; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGICAL STRESS; PSYCHOLOGICAL ASPECT;

AFFECT; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; FLUOROURACIL; LIVER; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TANDEM MASS SPECTROMETRY;

EID: 84862660917     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. XU J, MERCURY J, ZHANG Z, XU F. Psychological, social and behavioural factors that influence drug efficacy: A noteworthy research subject in clinical pharmacology. Br J Clin Pharmacol 2008; 66: 901-902.
2. LEE S, TSANG A, HUANG YQ, HE YL, LIU ZR, ZHANG MY, SHEN YC, KESSLER RC. The epidemiology of depression in metropolitan China. Psychol Med 2009; 39: 735-747.
3. XU F. Effect of personality type on pharmacodynamics through changing pharmacokinetics. Med Hypotheses 2007; 69: 1131-1134.
4. PENG HT, CHEUNG B. A review of psychophysiological stressors on pharmacokinetics. J Clin Pharmacol 2011; 51: 1499-1518.
5. GOLDHIRSCH A, COLLEONI M, COATES AS, CASTIGLIONEGERTSCH M, GELBER RD. Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Are all CMFs alike? The International Breast Cancer Study Group (IBCSG). Ann Oncol 1998; 9: 489-493.
6. BATEY MA, WRIGHT JG, AZZABI A, NEWELL DR, LIND MJ, CALVERT AH, BODDY AV. Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Eur J Cancer 2002; 38: 1081-1089.
7. MATALON ST, ORNOY A, LISHNER M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reprod Toxicol 2004; 18: 219-230.
8. CHU D, GU J, LIU W, PAUL FAWCETT J, DONG Q. Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 795: 377-382.
9. KATZ RJ, ROTH KA, CARROLL BJ. Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression. Neurosci Biobehav Rev 1981; 5: 247-251.
10. WILLNER P, TOWELL A, SAMPSON D, SOPHOKLEOUS S, MUSCAT R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987; 93: 358-364.
11. KENNETT GA, DICKINSON SL, CURZON G. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res 1985; 330: 253-263.
12. SCHAFER A, SCHEURLEN M, SEUFERT J, KEICHER C, WEISSBRICH B, RIEGER P, KRAUS MR. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression. J Hepatol 2010; 52: 10-15.
13. SASTRE RL, OLMO R, TEIJON C, MUNIZ E, TEIJON JM, BLANCO MD. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drugloaded microspheres prepared by spray-drying poly (D,L-lactide) and poly(D,L-lactide-coglycolide) polymers. Int J Pharm 2007; 338: 180-190.
14. COE RA, EARL RA, JOHNSON TC, LEE JW. Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method. J Pharm Biomed Anal 1996, 14:1733-1741.
15. EKHART C, GEBRETENSAE A, ROSING H, RODENHUIS S, BEIJNEN JH, HUITEMA AD. Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 2007; 854: 345-349.
16. KALHORN TF, HOWALD WN, COLE S, PHILLIPS B, WANG J, SLATTERY JT, MCCUNE JS. Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 835: 105-113.
17. THUERL C, OTTEN U, KNOTH R, MEYER RP, VOLK B. Possible role of cytochrome P450 in inactivation of testosterone in immortalized hippocampal neurons. Brain Res 1997; 762: 47-55.
18. SUNG JH, CHOI JR, KIM D, SHULER ML. Fluorescence optical detection in situ for real-time monitoring of cytochrome P450 enzymatic activity of liver cells in multiple microfluidic devices. Biotechnol Bioeng 2009; 104: 516-525.
19. PAPP M, WILLNER P, MUSCAT R. An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 1991; 104: 255-259.
20. KENNETT GA, CHAOULOFF F, MARCOU M, CURZON G. Female rats are more vulnerable than males in an animal model of depression: The possible role of serotonin. Brain Res 1986; 382: 416-421.
21. KITAMURA Y, ARAKI H, NAGATANI T, TAKAO K, SHIBATA K, GOMITA Y. Influence of imipramine on the duration of immobility in chronic forced-swim-stressed rats. Acta Med Okayama 2004; 58: 271-274.
22. WILLNER P. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl) 1997; 134: 319-329.
23. LIU M, HU J, MA T, WANG S, DING H. Application of a disposable screen-printed electrode to depression diagnosis for laboratory rats based on blood serotonin detection. Anal Sci 2011; 27: 839-843.
24. SPASOJEVIC N, GAVRILOVIC L, KOVACEVIC I, DRONJAK S. Effects of antidepressants maprotiline and fluxilan on sympatho-adrenomedullary system in stressed rats. Auton Neurosci 2009; 145: 104-107.
25. SONG C, ZHANG XY, MANKU M. Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: Effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 2009; 29: 14-22.
26. VON POSER TOIGO E, DIEHL LA, FERREIRA AG, MACKENDANZ V, KROLOW R, BENITZ AN, NOSCHANG C, HUFFELL AP, SILVEIRA PP, WYSE AT, DALMAZ C. Maternal depression model: Long-lasting effects on the mother following separation from pups. Neurochem Res 2011; Ahead of print.
27. VON POSER TOIGO E, DIEHL LA, FERREIRA AG, MACKENDANZ V, KROLOW R, BENITZ AN, NOSCHANG C, HUFFELL AP, SILVEIRA PP, WYSE AT, DALMAZ C. Maternal depression model: Long-lasting effects on the mother following separation from pups. Neurochem Res 2012; 37: 126-133.
28. ABOLMAALI K, BALAKRISHNAN A, STEARNS AT, ROUNDS J, RHOADS DB, ASHLEY SW, TAVAKKOLIZADEH A. Circadian variation in intestinal dihydropyrimidine dehydrogenase (DPD) expression: A potential mechanism for benefits of 5FU chrono-chemotherapy. Surgery 2009; 146: 269-273.
29. ZHOU GP, ZHOU, T, XU, F. Effect of depression on DPD levels in malignant cancer patients. Pharm Today 2010; 20: 4.
30. SHAMS ME, ARNETH B, HIEMKE C, DRAGICEVIC A, MULLER MJ, KAISER R, LACKNER K, HARTTER S. CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 2006; 31: 493-502.
31. DORADO P, PENAS-LLEDO EM, LLERENA A. CYP2D6 polymorphism: Implications for antipsychotic drug response, schizophrenia and personality traits. Pharmacogenomics 2007; 8: 1597-1608.
32. GONZALEZ I, PENAS-LLEDO EM, PEREZ B, DORADO P, ALVAREZ M, A LL. Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers. Pharmacogenomics 2008; 9: 833-840.